Rosetta Genomics Ltd. Realized Gains on Marketable Securities
Rosetta Genomics Ltd. reported Realized Gains on Marketable Securities of $2.00 thousand for the 12-month period ending 2011-12-31, per its 20-F filed 2014-03-31.
Discontinued › Income Statement › Other Income
us-gaap:MarketableSecuritiesRealizedGainLoss · last filed 2014-03-31
| Period end | Marketable Securities, Realized Gain (Loss) 12 month |
|---|---|
| 2011-12-31 | $2.00K 20-F · filed 2014-03-31 |
| 2010-12-31 | $208.00K 20-F · filed 2013-03-22 |